Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 8Unknown 7Recruiting 3Active not recruiting 3Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 1

Interventions

Surgical Procedures, Operative 2Music Therapy 2Letrozole 2Fluorodeoxyglucose F18 2Drug Therapy 2exemestane 1dalpiciclib 1Zoledronic Acid 1Vitamin D 1Tamoxifen 1Synbiotics 1Resistance Training 1Relaxation Therapy 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Prebiotics 1Oxygen Inhalation Therapy 1Neoadjuvant Therapy 1Mastectomy, Segmental 1Mastectomy, Modified Radical 1Mastectomy 1Mannitol 1Magnetic Resonance Imaging 1Interviews as Topic 1Hyperbaric Oxygenation 1Educational Status 1Echocardiography 1Diagnostic Imaging 1Combined Modality Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Breast Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT06890871 2025-03-24

Radiotherapy with Immunotherapy and Anti-Angiogenic Therapy for Advanced HER2-Negative Breast Cancer: a Single-Arm Study

Zhongnan Hospital

Phase 1/2 Enrolling by invitation
25 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡